NCT02762799View on ClinicalTrials.gov

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

November 11, 2016

Study Completion Date

November 11, 2016

Conditions
Leucocytosis
Interventions
BIOLOGICAL

Leucostim®

Leucostim® is filgrastim biosimilar.

BIOLOGICAL

Neupogen®

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY